keyword
MENU ▼
Read by QxMD icon Read
search

2016 esc guidelines

keyword
https://www.readbyqxmd.com/read/28763821/-esc-guidelines-2016-heart-failure
#1
Lucas Adrian, Christian Werner, Ulrich Laufs
No abstract text is available yet for this article.
August 2017: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/28751436/a-striking-image-of-spontaneous-echo-contrast-in-severe-mitral-stenosis-in-a-patient-with-good-international-normalised-ratio-inr-control
#2
Daniel A Jeffery, Guy Lloyd, Arjun K Ghosh
No abstract text is available yet for this article.
September 2017: Echo Research and Practice
https://www.readbyqxmd.com/read/28685644/summary-of-2016-esc-guidelines-on-heart-failure-atrial-fibrillation-dyslipidaemia-and-cardiovascular-prevention
#3
Marc J Claeys, Wilfried Mullens, Yves Vandekerckhove, Mattias Duytschaever, Catherine De Maeyer, Agnes Pasquet
During the ESC congress in September 2016 in Rome, the new ESC guidelines were presented and are now available on the ESC website ( http://www.escardio.org/guidelines ). The new guidelines cover management recommendations on following cardiovascular items: Heart failure, atrial fibrillation, dyslipidemia and cardiovascular prevention. The present document gives a summary of these guidelines and highlights the most important recommendations and changes in the management of these diseases. It will help to increase awareness about the new guidelines and may stimulate to consult the full document for specific items...
July 7, 2017: Acta Cardiologica
https://www.readbyqxmd.com/read/28618902/secondary-prevention-where-we-are
#4
Ugo Corrà, Massimo F Piepoli
The Sixth Joint Task Force of the European Society of Cardiology (ESC) and Other Societies on Cardiovascular Disease Prevention in Clinical Practice Guidelines have been published in 2016: greater emphasis has been placed on a population-based approach, on disease-specific interventions and on female-specific conditions, younger individuals and ethnic minorities. The ESC guidelines underscore that a lifetime approach to cardiovascular risk is important as both risk and prevention are dynamic and continuous...
June 2017: European Journal of Preventive Cardiology
https://www.readbyqxmd.com/read/28564733/-update-dyslipidaemias-comments-on-the-2016-esc-eas-guidelines-for-the-management-of-dyslipidaemias
#5
David Sinning, Ulf Landmesser
No abstract text is available yet for this article.
June 2017: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/28451445/who-are-patients-classified-within-the-new-terminology-of-heart-failure-from-the-2016-esc-guidelines
#6
Benoit Delepaul, Guillaume Robin, Clément Delmas, Thomas Moine, Adrien Blanc, Pauline Fournier, Aénora Roger-Rollé, Guillaume Domain, Clémence Delon, Charles Uzan, Rabah Boudjellil, Didier Carrié, Jérôme Roncalli, Michel Galinier, Olivier Lairez
AIMS: The main terminology used to describe heart failure (HF) is based on measurement of the left ventricular ejection fraction (LVEF). LVEF in the range of 40-49% was recently defined as HF with mid-range EF (HFmrEF) by the 2016 European Society of Cardiology guidelines. The purpose of our study was to assess the clinical profile and prognosis of patients with HF according to this new classification. METHODS AND RESULTS: A total of 482 patients referred for HF were retrospectively included over a period of 1 year...
May 2017: ESC Heart Failure
https://www.readbyqxmd.com/read/28424431/-2016-esc-eas-guidelines-for-the-management-of-dyslipidaemias-what-is-new
#7
EDITORIAL
Meral Kayıkçıoğlu, Lale Tokgözoğlu
No abstract text is available yet for this article.
March 2017: Türk Kardiyoloji Derneği Arşivi: Türk Kardiyoloji Derneğinin Yayın Organıdır
https://www.readbyqxmd.com/read/28402409/corrigendum-to-2016-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-failure
#8
(no author information available yet)
No abstract text is available yet for this article.
April 10, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28369313/corrigendum-to-2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-collaboration-with-eacts
#9
(no author information available yet)
No abstract text is available yet for this article.
March 27, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28363217/acc-aha-guidelines-superior-to-esc-eas-guidelines-for-primary-prevention-with-statins-in-non-diabetic-europeans-the-copenhagen-general-population-study
#10
Martin Bødtker Mortensen, Børge G Nordestgaard, Shoaib Afzal, Erling Falk
Aim: We compared the 2013 American College of Cardiology/American Heart Association (ACC/AHA) and the 2016 European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) guidelines on prevention of atherosclerotic cardiovascular disease (ASCVD) using different risk prediction models [US Pooled Cohort Equations (US-PCE for any ASCVD) and European Systematic COronary Risk Evaluation system (European-SCORE for fatal ASCVD)] and different statin eligibility criteria. Methods and results: We examined 44 889 individuals aged 40-75 recruited in 2003-09 in the Copenhagen General Population Study, all free of ASCVD, diabetes, and statin use at baseline...
February 21, 2017: European Heart Journal
https://www.readbyqxmd.com/read/28345190/new-medicinal-products-for-chronic-heart-failure-advances-in-clinical-trial-design-and-efficacy-assessment
#11
REVIEW
Martin R Cowie, Gerasimos S Filippatos, Maria de Los Angeles Alonso Garcia, Stefan D Anker, Anna Baczynska, Daniel M Bloomfield, Maria Borentain, Karsten Bruins Slot, Maureen Cronin, Pieter A Doevendans, Amany El-Gazayerly, Claudio Gimpelewicz, Narimon Honarpour, Salim Janmohamed, Heidi Janssen, Albert M Kim, Dominik Lautsch, Ian Laws, Martin Lefkowitz, Jose Lopez-Sendon, Alexander R Lyon, Fady I Malik, John J V McMurray, Marco Metra, Santiago Figueroa Perez, Marc A Pfeffer, Stuart J Pocock, Piotr Ponikowski, Krishna Prasad, Isabelle Richard-Lordereau, Lothar Roessig, Giuseppe M C Rosano, Warren Sherman, Wendy Gattis Stough, Karl Swedberg, Benoit Tyl, Faiez Zannad, Caroline Boulton, Pieter De Graeff
Despite the availability of a number of different classes of therapeutic agents with proven efficacy in heart failure, the clinical course of heart failure patients is characterized by a reduction in life expectancy, a progressive decline in health-related quality of life and functional status, as well as a high risk of hospitalization. New approaches are needed to address the unmet medical needs of this patient population. The European Medicines Agency (EMA) is undertaking a revision of its Guideline on Clinical Investigation of Medicinal Products for the Treatment of Chronic Heart Failure...
June 2017: European Journal of Heart Failure
https://www.readbyqxmd.com/read/28284631/correction-in-the-spanish-translation-of-the-article-by-ponikowski-et-al-2016-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart-failure-rev-esp-cardiol-2016-69-1167-e1-e85
#12
https://www.readbyqxmd.com/read/28187483/-esc-guidelines-2016-prevention-of-cardiovascular-diseases-in%C3%A2-clinical-practice
#13
Harm Wienbergen, Rainer Hambrecht
No abstract text is available yet for this article.
February 2017: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/28131410/comments-on-the-2016-esc-eas-guidelines-for-the-management-of-dyslipidemias
#14
COMMENT
L Pérez de Isla, Leopoldo Pérez de Isla, Pedro Luis Sánchez Fernández, Luis Álvarez-Sala Walther, Vivencio Barrios Alonso, Almudena Castro Conde, Enrique Galve Basilio, Luis García Ortiz, Pedro Mata López, Eduardo Alegría Ezquerra, Alberto Cordero Fort, Juan Cosin Sales, Carlos Escobar Cervantes, Xavier García-Moll Marimón, Juan José Gómez Doblas, Domingo Marzal Martín, Nekane Murga Eizagaechevarria, Carmen de Pablo Zarzosa, Luis Miguel Rincón, Juan Sanchis Forés, José Alberto San Román Calvar, Fernando Alfonso Manterola, Fernando Arribas Ynsaurriaga, Arturo Evangelista Masip, Ignacio Ferreira González, Manuel Jiménez Navarro, Francisco Marín Ortuño, Leopoldo Pérez de Isla, Luis Rodríguez Padial, Pedro Luis Sánchez Fernández, Alessandro Sionis Green, Rafael Vázquez García
No abstract text is available yet for this article.
February 2017: Revista Española de Cardiología
https://www.readbyqxmd.com/read/28077464/integrated-care-of-patients-with-atrial-fibrillation-the-2016-esc-atrial-fibrillation-guidelines
#15
EDITORIAL
Paulus Kirchhof
No abstract text is available yet for this article.
May 2017: Heart: Official Journal of the British Cardiac Society
https://www.readbyqxmd.com/read/28076703/a-systematic-review-to-assess-adherence-and-persistence-with-statins
#16
Sohan Deshpande, Ruben G W Quek, Carol A Forbes, Shelley de Kock, Jos Kleijnen, Shravanthi R Gandra, Ross J Simpson
OBJECTIVE: To identify and assess studies published over a 10 year period up to February 2016 which measure adherence or persistence with statins, to summarize their methods, strengths and weaknesses and to summarize evidence linking statin adherence/persistence with risk of cardiovascular events. METHODS: Electronic databases and abstracts from four major cardiovascular disease conferences were searched from January 2005 to February 2016. The study selection process was performed by two reviewers working independently...
April 2017: Current Medical Research and Opinion
https://www.readbyqxmd.com/read/28058458/-vitamin-k-antagonists-is-their-prescription-really-medical-malpractice-%C3%A2-today
#17
E Rafflenbeul, J Müller-Ehmsen
Atrial fibrillation and venous thromboembolisms are frequent cardiovascular diseases. Until a few years ago only vitamin K antagonists (VKA) were available for oral anticoagulation as primary and secondary prevention of thrombembolic events. Currently, the non-vitamin K dependent new oral anticoagulants (NOAC) dabigatran, rivaroxaban, apixaban and edoxaban are approved for use. The approval studies, meta-analyses and data from registries provide evidence for the superiority of NOAC vs. VKA with respect to reduction of thrombembolisms and reduced bleeding complications; therefore, in the 2016 European Society of Cardiology (ESC) guidelines the use of NOAC is recommended as first line therapy for anticoagulation in atrial fibrillation (recommendation grade I/evidence level A)...
January 2017: Der Internist
https://www.readbyqxmd.com/read/28045408/-2016-esc-and-acc-aha-hfsa-heart-failure-guideline-updates-changes-similarities-differences-and-unresolved-isssues
#18
EDITORIAL
İbrahim Sarı, Yüksel Çavuşoğlu, Ahmet Temizhan, Mehmet Birhan Yılmaz, Mehmet Eren
No abstract text is available yet for this article.
December 2016: Türk Kardiyoloji Derneği Arşivi: Türk Kardiyoloji Derneğinin Yayın Organıdır
https://www.readbyqxmd.com/read/28038729/2016-esc-guidelines-for-the-management-of-atrial-fibrillation-developed-in-collaboration-with-eacts
#19
Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei, Manuel Castellá, Hans-Christoph Diener, Hein Heidbuchel, Jeroen Hendriks, Gerhard Hindricks, Antonis S Manolis, Jonas Oldgren, Bogdan Alexandru Popescu, Ulrich Schotten, Bart Van Putte, Panagiotis Vardas
No abstract text is available yet for this article.
January 2017: Revista Española de Cardiología
https://www.readbyqxmd.com/read/28038728/comments-on-the-2016-esc-guidelines-for-the-management-of-atrial-fibrillation
#20
EDITORIAL
F Arribas, Fernando Arribas, Inmaculada Roldán, José Luis Merino, Vanessa Roldán, Ÿngel Arenal, Juan Tamargo, Ricardo Ruiz-Granell, Lluís Mont, Manuel Anguita, Francisco Marín, Vivencio Barrios Alonso, Gonzalo Barón, Esquivias, Juan Cosín Sales, Ernesto Díaz Infante, Carlos Escobar Cervantes, José Luis Ferreiro Gutiérrez, José M Guerra Ramos, Francisco Javier Jiménez Candil, Nicasio Pérez Castellano, Antonia Sambola Ayala, Antonio Tello Montoliu, Alberto San Román, Fernando Alfonso, Fernando Arribas, Arturo Evangelista, Ignacio Ferreira, Manuel Jiménez, Francisco Marín, Leopoldo Pérez de Isla, Luis Rodríguez Padial, Pedro L Sánchez, Alessandro Sionis, Rafael Vázquez
No abstract text is available yet for this article.
January 2017: Revista Española de Cardiología
keyword
keyword
106650
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"